Showing results (191-200 of 291) with videos related to
Sort By:
Pageof 30
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2014
HIP1-ALK, a novel fusion protein identified in lung adenocarcinomaMineui Hong, Ryong Nam Kim, Ji-Young Song, et al.Cell Transplantation|July 23, 2009
ERas is expressed in primate embryonic stem cells but not related to tumorigenesisYujiro Tanaka, Tamako Ikeda, Yukiko Kishi, et al.International Journal of Clinical and Experimental Pathology|January 16, 2014
A probable identical Epstein-Barr virus clone-positive composite lymphoma with aggressive natural killer-cell leukemia and cytotoxic T-cell lymphomaKei-Ji Sugimoto, Asami Shimada, Mutsumi Wakabayashi, et al.Cancer Cytopathology|June 20, 2022
Machine learning-based gene alteration prediction model for primary lung cancer using cytologic imagesShuhei Ishii, Manabu Takamatsu, Hironori Ninomiya, et al.Experimental Hematology & Oncology|December 6, 2012
R-CHOP with dose-attenuated radiation therapy could induce good prognosis in gastric diffuse large B cell lymphomaYuko Mishima, Yasuhito Terui, Masahiro Yokoyama, et al.International Journal of Hematology|January 20, 2016
ALK-positive large B-cell lymphoma: identification of EML4-ALK and a review of the literature focusing on the ALK immunohistochemical staining patternKana Sakamoto, Hideki Nakasone, Yuki Togashi, et al.The Journal of Experimental Medicine|March 16, 2019
Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non-small cell lung cancerBo Gong, Kazuma Kiyotani, Seiji Sakata, et al.Journal of Clinical Pathology|November 13, 2013
Epstein-Barr virus is rarely associated with diffuse large B cell lymphoma in Taiwan and carries a trend for a shorter median survival timeSheng-Tsung Chang, Yi-Hsuan Lu, Chin-Li Lu, et al.Thoracic Cancer|December 22, 2020
Feasibility of next-generation sequencing test for patients with advanced NSCLC in clinical practiceRyo Ariyasu, Ken Uchibori, Hironori Ninomiya, et al.Lung Cancer (Amsterdam, Netherlands)|February 23, 2016
Sorafenib treatment for patients with RET fusion-positive non-small cell lung cancerAtsushi Horiike, Kengo Takeuchi, Takeshi Uenami, et al.Pageof 30